# Patient Safety and Complications in Plastic Surgery

## Introduction

**Patient safety** is the cornerstone of surgical practice; plastic surgery encompasses both elective aesthetic and complex reconstructive procedures, each with unique risk profiles. The **elective nature** of many plastic surgery procedures places an even higher ethical obligation on the surgeon to minimize risk. Complications range from minor (wound infection, seroma) to catastrophic (pulmonary embolism, anesthetic death, wrong-site surgery). A culture of **safety, transparency, and continuous quality improvement** is essential in all practice settings.

Key frameworks include the **WHO Surgical Safety Checklist**, enhanced recovery after surgery (ERAS) protocols, and institutional peer review.

## Preoperative Risk Assessment

### Patient Selection

**American Society of Anesthesiologists (ASA) classification**: stratifies patients by comorbidity burden; ASA III-IV patients have significantly higher perioperative complication rates. **Body mass index (BMI)**: obesity (BMI >30) increases wound complications, DVT, PE, and anesthetic risk; morbid obesity (BMI >40) is a relative contraindication for many elective procedures. **Smoking**: vasoconstriction from nicotine causes tissue ischemia; smokers have **3-6x higher risk** of wound complications, flap necrosis, and delayed healing. Smoking cessation for a minimum of **4-6 weeks** preoperatively and postoperatively is strongly recommended.

**Diabetes**: HbA1c >7% associated with increased surgical site infections; optimize glycemic control preoperatively. **Medications**: anticoagulants, antiplatelet agents, herbal supplements (ginkgo, garlic, ginseng, vitamin E) increase bleeding risk; discontinue per protocol.

### Venous Thromboembolism Risk Assessment

**Caprini Risk Assessment Model**: validated for plastic surgery; scores patients based on age, BMI, surgery type/duration, history of VTE, immobilization, and other factors.

| Caprini Score | Risk Level | Prophylaxis |
|:-------------:|-----------|-------------|
| 0-4 | Low | Early ambulation alone |
| 5-6 | Moderate | Mechanical (SCDs, compression stockings) |
| 7-8 | High | Mechanical + chemoprophylaxis (enoxaparin 40 mg SQ daily) |
| >=9 | Highest | Extended chemoprophylaxis (up to 30 days) |

**Abdominoplasty + another procedure** is an independent risk factor for VTE; consider chemoprophylaxis.

### Informed Consent

Must include **specific risks** relevant to the planned procedure, general surgical risks, alternatives, and expected outcomes. Discuss **realistic expectations** particularly in aesthetic surgery; identify patients with **body dysmorphic disorder (BDD)** who may have unrealistic expectations and poor satisfaction regardless of outcome. Shared decision-making with documentation of the consent conversation. Photographic documentation with **standardized views** is both a clinical tool and medicolegal protection.

<image>Flowchart showing the preoperative risk assessment pathway for plastic surgery patients: initial screening (ASA class, BMI, smoking, diabetes), Caprini VTE risk scoring with corresponding prophylaxis recommendations, psychological screening for body dysmorphic disorder, and the informed consent process with documentation requirements</image>

## Intraoperative Safety

### WHO Surgical Safety Checklist

Three phases: **Sign In** (before anesthesia), **Time Out** (before incision), and **Sign Out** (before patient leaves OR). Verified elements: patient identity, procedure and site, consent, allergies, airway assessment, blood loss risk, antibiotic prophylaxis, equipment availability. Implementation reduces surgical complications by **36%** and mortality by **47%** (Haynes et al., 2009). **Site marking**: mark the operative site with indelible ink while the patient is awake; prevents wrong-site surgery.

### Anesthesia Considerations

**Office-based surgery**: increasing proportion of plastic surgery performed in office-based operating rooms (OBORs); requires adherence to accreditation standards (AAAASF, AAAHC, Joint Commission). **Maximum procedure duration**: OBOR guidelines generally limit procedures to **6 hours**; combined procedures exceeding this increase complication rates. **Malignant hyperthermia**: rare but life-threatening hypermetabolic response to halogenated anesthetics and succinylcholine; dantrolene must be immediately available. **Local anesthetic toxicity**: lidocaine (4.5 mg/kg without epinephrine, 7 mg/kg with epinephrine); tumescent doses up to 35-55 mg/kg; signs include circumoral numbness, tinnitus, seizures, cardiac arrest; treat with **lipid emulsion (Intralipid 20%)**.

### Surgical Technique and Hemostasis

**Meticulous hemostasis** reduces hematoma, seroma, and revision rates; electrocautery, topical hemostatic agents, and drain placement as appropriate. **Surgical drains**: reduce dead space and fluid collections; remove when output falls below threshold (typically 30 mL/24 hours). **Temperature management**: hypothermia increases bleeding, infection risk, and cardiac events; maintain normothermia with forced-air warming.

## Common Complications

### Hemorrhage and Hematoma

**Hematoma** is the most common early complication requiring reoperation in many plastic surgery procedures (facelift: 3-8%; breast augmentation: 1-2%; abdominoplasty: 1-3%). Risk factors: uncontrolled **hypertension** (most common modifiable factor in facelift hematoma), anticoagulant use, coagulopathy. **Postoperative hypertension** management is critical; consider beta-blockers or clonidine in the recovery room. Treatment: early recognition and **surgical evacuation**; delay increases risk of skin flap necrosis and infection.

### Surgical Site Infection (SSI)

Overall SSI rate in plastic surgery: **1-5%**; higher in contaminated and irradiated wounds. **Prophylactic antibiotics**: cefazolin 2g IV within 60 minutes of incision for clean procedures involving implants or prolonged operative time; duration should not exceed **24 hours** postoperatively. **Implant-related infections**: present early (acute bacterial) or late (biofilm-associated); may require implant removal. **Antibiotic stewardship**: extended postoperative antibiotics do not reduce SSI and contribute to antibiotic resistance.

### Seroma

Collection of serous fluid in a surgical dead space; common after abdominoplasty (5-15%), breast surgery, and body contouring. Prevention: **progressive tension sutures** (quilting sutures) in abdominoplasty reduce seroma from 15% to <1%; drains; compression garments. Treatment: serial aspiration; persistent seromas may require sclerotherapy or surgical revision.

### Wound Dehiscence

Risk factors: tension on closure, infection, smoking, diabetes, malnutrition, steroid use. Prevention: tension-free closure, layered technique, optimizing nutritional status (prealbumin >15 mg/dL). Management: local wound care for small dehiscence; surgical revision for large or functionally significant wounds.

### Venous Thromboembolism

**DVT/PE** is the leading cause of death after plastic surgery, particularly after body contouring procedures. Combined abdominoplasty with other procedures: DVT rate up to **1.4%**; PE rate **0.8%**. Prevention: Caprini risk stratification, mechanical prophylaxis, early ambulation, chemoprophylaxis for high-risk patients. Recognition: dyspnea, tachycardia, pleuritic chest pain, lower extremity swelling; **CT angiography** for diagnosis; initiate anticoagulation immediately if suspected.

### Fat Embolism Syndrome

Associated with **large-volume liposuction** and orthopedic procedures. Classic triad: respiratory distress, neurological changes, **petechial rash** (24-72 hours postoperatively). Treatment is supportive: supplemental oxygen, mechanical ventilation, hemodynamic support.

<image>Infographic summarizing the major complications in plastic surgery organized by system: surgical (hematoma, seroma, wound dehiscence, SSI), thromboembolic (DVT, PE, fat embolism), anesthetic (malignant hyperthermia, local anesthetic toxicity), and patient-related (hypertrophic scarring, chronic pain, dissatisfaction), with incidence rates and key prevention strategies for each</image>

## Patient Safety in Aesthetic Surgery

### Combined Procedures

Combining multiple procedures (e.g., abdominoplasty + breast augmentation + liposuction, "mommy makeover") increases operative time, blood loss, and complication rates. Guidelines recommend limiting total operative time to **6 hours** and combining no more than **2-3 procedures**. **Large-volume liposuction (>5 L)** combined with other procedures significantly increases risk; should be avoided or performed with overnight monitoring.

### Office-Based Surgery Safety

Accreditation by AAAASF, AAAHC, or state licensing board ensures compliance with equipment, staffing, and emergency protocol standards. Required: **crash cart, defibrillator, malignant hyperthermia kit (dantrolene), Intralipid**, and transfer agreement with a nearby hospital. Surgeon must have **hospital admitting privileges** or a transfer agreement. Patient selection: ASA I-II only for office-based procedures under general anesthesia; ASA III with well-controlled conditions for local/MAC procedures.

### Medical Tourism and Safety Concerns

Patients seeking surgery abroad may face inadequate facility accreditation, language barriers, lack of postoperative follow-up, and complications presenting remotely. Surgeons managing complications from medical tourism should document findings, provide appropriate care, and counsel patients on risks of future surgery abroad.

## Quality Improvement

**Morbidity and mortality conferences**: systematic review of adverse outcomes; non-punitive, educational environment. **NSQIP (National Surgical Quality Improvement Program)**: ACS-sponsored outcomes database; risk-adjusted benchmarking of surgical outcomes. **Tracking and Reporting Outcomes for Patient Safety (TOPS)**: ASPS-specific database for plastic surgery quality metrics. **Checklists and protocols**: standardized preoperative, intraoperative, and postoperative protocols reduce variability and error.

**Root cause analysis**: systematic investigation of adverse events to identify system-level failures rather than individual blame.

<image>Timeline illustration showing the patient safety journey in plastic surgery: preoperative phase (risk assessment, consent, optimization), intraoperative phase (WHO checklist, time-out, temperature management, hemostasis), and postoperative phase (VTE prophylaxis, drain management, complication surveillance, follow-up schedule)</image>

## Key Clinical Pearls

The Caprini Risk Assessment Model should be applied to every surgical patient; VTE is the leading cause of death after plastic surgery and is largely preventable. Smoking cessation for 4-6 weeks preoperatively is non-negotiable for elective procedures involving skin flaps or tissue expansion. The WHO Surgical Safety Checklist has been proven to reduce complications and mortality; it should be used for every case regardless of setting. Combined procedures should be limited in duration and complexity; large-volume liposuction should not be combined with other major procedures in an outpatient setting. Progressive tension sutures in abdominoplasty have dramatically reduced seroma rates and may allow drain-free procedures.

## References

1. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. *N Engl J Med*. 2009;360(5):491-499.
2. Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. *J Am Coll Surg*. 2011;212(1):105-112.
3. Pollock H, Pollock T. Progressive tension sutures: a technique to reduce local complications in abdominoplasty. *Plast Reconstr Surg*. 2000;105(7):2583-2586.
4. Iverson RE, ASPS Task Force on Patient Safety in Office-Based Surgery Facilities. Patient safety in office-based surgery facilities: I. Procedures in the office-based surgery setting. *Plast Reconstr Surg*. 2002;110(5):1337-1342.